mutations of glutathione s-transferase The role glutathione-S-transferase in anti-cancer drug resistance Frontiers | Case report: A
Description
Mehdi et al., 2013)
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
S1d online)
In one study, GSH was administered intravenously to patients with advanced neoplastic disease, in two divided doses of 2,500 mg, shortly before and after doses of cyclophosphamide
